It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Opportunities to decrease inappropriate uses of proton pump inhibitors: Comment on "Proton pump inhibitor use and the antifracture efficacy of alendronate".
https://arctichealth.org/en/permalink/ahliterature137046
Source
Arch Intern Med. 2011 Jun 13;171(11):1004-5
Publication Type
Article
Date
Jun-13-2011
More detail
Author
Mitchell H Katz
Author Affiliation
Los Angeles Department of Health Services, CA 90012, USA. mhkatz59@yahoo.com
Source
Arch Intern Med. 2011 Jun 13;171(11):1004-5
Date
Jun-13-2011
Language
English
Publication Type
Article
Keywords
Alendronate - administration & dosage - adverse effects
Bone Density Conservation Agents - administration & dosage - adverse effects
Denmark - epidemiology
Dose-Response Relationship, Drug
Drug Interactions
Gastrointestinal Hemorrhage - chemically induced
Hip Fractures - epidemiology - prevention & control
Humans
Proton Pump Inhibitors - administration & dosage - adverse effects
Risk
Notes
Comment On: Arch Intern Med. 2011 Jun 13;171(11):998-100421321287
PubMed ID
21321289
View in PubMed
Less detail
Permalink